|
WO2020112898A1
|
|
Methods to improve beverage quality
|
|
AU2018249556A1
|
|
Improved method for isolation of MAO inhibitors from tequila or other distilled agave fermentation products
|
|
EP3194557A1
|
|
Energy drinks and other nutritional aids derived from agave-based spirits
|
|
US10495652B1
|
|
Determination of LCAT
|
|
US2013196340A1
|
|
Ex vivo plasma enzyme activity assay using inhibitors as a negative control
|
|
US2005233401A1
|
|
Method to detect emphysema
|
|
WO03087396A1
|
|
Ex vivo method for determination of cetp activity and efficacy of heart disease treatment
|
|
US7618784B2
|
|
Assay for phospholipid transfer protein (PLTP) activity
|
|
US6974676B1
|
|
Assay methods for transfer proteins that normalize for acceptor concentration
|
